Abstracts tagged "Anticoagulation and antiphospholipid"

Abstract Number: 2176 • 2015 ACR/ARHP Annual Meeting
The Ability of Recombinant Domain I of Beta-2-Glycoprotein I to Inhibit Lupus Anticoagulant Effect of IgG from Patients with APS Is Enhanced By Pegylation
Thomas McDonnell¹, Charis Pericleous¹, Ian Giles¹, Yiannis Ioannou² and Anisur Rahman¹, ¹Rayne Institute, Centre for Rheumatology Research, UCL Division of Medicine, London, United Kingdom, ²Rayne Institute, Arthritis Research UK Centre for Adolescent Rheumatology, UCL Division of Medicine, London, United Kingdom
Background/Purpose: Antiphospholipid Syndrome (APS) is an autoimmune rheumatic disorder in which antiphospholipid antibodies (aPL) cause clinical events including vascular thrombosis (VT) and pregnancy morbidity (PM).…